USP22-ATP2A3 Fusion FISH Probe
The USP22-ATP2A3 Fusion FISH Probe is used to confirm a fusion of the USP22 and ATP2A3 genes. The fusion of the USP22 and ATP2A3 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| USP22-ATP2A3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| USP22-ATP2A3-20-AQAQ | 20 (40 μL) | 200 μL |
|
ATP2A3 Gene Summary
This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of muscle cells. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen, and is involved in calcium sequestration associated with muscular excitation and contraction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Gene Name: ATPase Sarcoplasmic/endoplasmic Reticulum Ca2+ Transporting 3
Chromosome: CHR17: 3827162 -3867758
Locus: 17p13.2
USP22 Gene Summary
The Ubiquitin Specific Peptidase 22 (USP22) gene is located on chr17 :20902905-20946352 at 17p11.2.
Gene Name: Ubiquitin Specific Peptidase 22
Chromosome: CHR17: 20902905 -20946352
Locus: 17p11.2
Gene Diseases
The USP22 ATP2A3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|